Intellia Therapeutics to Present at Three Key Healthcare Conferences in March
Event summary
- Intellia Therapeutics will participate in three investor conferences in March 2026.
- Fireside chats scheduled for March 3 and March 9 will be webcast live.
- Replays of the webcasts will be available for 90 days post-event.
- Conferences include TD Cowen, Leerink Global Healthcare, and Barclays Global Healthcare.
The big picture
Intellia’s participation in these high-profile conferences underscores its push to engage with investors amid a rapidly evolving gene-editing sector. The events come as CRISPR-based therapies gain traction, with Intellia aiming to differentiate itself through its platform capabilities and clinical pipeline. The focus will likely be on execution and regulatory progress as the company seeks to validate its long-term strategy.
What we're watching
- Pipeline Updates
- How Intellia will position its CRISPR-based therapies in a competitive landscape.
- Investor Sentiment
- Whether the presentations will shift market perception of Intellia’s growth trajectory.
- Regulatory Progress
- The pace at which Intellia advances its clinical-stage programs through regulatory milestones.
Related topics